C almodulin (CaM) is a Ca 2+ -sensing protein that is expressed in all eukaryotic cells. It mediates many essential processes driven by Ca 2+ , including long-term changes in synaptic connections in the brain 1 , apoptosis 2 , and immune responses 3 . CaM is a bilobal protein, with each lobe consisting of two EF hands that adopt an open conformation upon binding Ca 2+ . Ca 2+ /CaM binds and modulates a wide range of proteins. For example, Ca 2+ /CaM-binding relieves autoinhibition in the phosphatase calcineurin and in Ca 2+ /CaM-dependent protein kinase II (CaMKII). CaM possesses a highly flexible structure that is capable of recognizing a diversity of interaction motifs. Many recognition motifs for Ca 2+ /CaM fall within two major classes 4 . Proteins including myosin light chain kinase 5 and calcineurin present amphiphilic helices with anchor hydrophobic residues at positions 1, 8, and 14, whereas proteins including CaMKII 6 bind CaM through shorter helical sequences with the hydrophobic anchors at position 1, 5, and 10. High-resolution crystal and NMR structures have established how both lobes of CaM act in concert to coordinate either 1-5-10 or 1-8-14 class motifs 7, 8 . Outside of these predominant classes, in a few cases Ca 2+ /CaM binds in an extended conformation to longer recognition sequences 9 . For example, Munc13 presents a 1-5-8-26 pattern of hydrophobic amino acids for interaction with Ca 2+ /CaM 10 . Prior to this study, in all cases where CaM binding depends on Ca 2+ , all four EF hands have been found to bind Ca 2+ in high-resolution structures. In addition, with a single exception 11 , the terminal hydrophobic anchor positions are separated by no fewer than eight amino acids. Despite decades of progress in understanding CaM recognition sequences, CaM-binding sites in some Ca 2+ /CaM-regulated proteins have eluded mapping. One such protein is AKAP79, which was the focus of this investigation. AKAP79 (rodent ortholog AKAP150, gene name AKAP5) is a prototypic A-kinase-anchoring protein (AKAP) that fulfills key physiological roles, including supporting long-term synaptic depression 12 , directing calcineurin for NFAT dephosphorylation 13 , and controling release and response to insulin 14 . AKAP79 engages in multiple protein-protein interactions, including with cAMP-dependent protein kinase (PKA) 15 , calcineurin 16 and Ca 2+ /CaM 17 . The calcineurin-binding site on AKAP79 has been proposed as a drug target 14, 18 for treating diabetes 14, 18 . It also interacts with the membrane bilayer through a combination of N-terminal polybasic regions 19 and double palmitoylation 20, 21 . Constitutive binding sites for calcineurin and PKA have been mapped within AKAP79: PKA binds to an amphipathic helix near to the anchoring protein's C-terminus 15 , whereas calcineurin binds to the sequence PIAIIITD between AKAP79 residues 337 and 343 19 . Initial mapping of these two anchoring sites has been corroborated by high-resolution structures [22] [23] [24] , leading to functional investigations using AKAP79 variants containing targeted ablations 12, 14 . Binding of Ca 2+ /CaM within the first 153 amino acids of AKAP79 25 antagonizes interactions between the tandem basic regions of the protein and acidic headgroups of the membrane bilayer 19 . Ca 2 + /CaM also stabilizes interactions between AKAP79 and calcineurin by triggering a secondary interface with the phosphatase that involves elements in the N-terminus of AKAP79 25 , although it is not clear how CaM triggers this interface. AKAP79 contains no sequences conforming to 1-5-10 or 1-8-14 motifs, and the absence of a precise location for CaM binding has impeded progress in understanding how CaM regulates AKAP79.
We set out to determine the CaM-binding site in AKAP79 by exploiting the rapidly developing technique cross-linking coupled to mass spectrometry (XL-MS). The general approach is to crosslink proteins under native conditions, followed by detection and exact sequence identification of cross-linked peptides by MS ( Fig. 1a) 26 . The interlinking pattern between CaM and AKAP79 served as a foundation for identifying and characterizing the CaM-binding site in AKAP79.
Results
Analysis of cross-linking CaM in complex with AKAP79. We first purified AKAP79 bound to the dimerization and docking (D/ D) domain of type IIα PKA regulatory subunits ( Supplementary  Fig. 1a, b ). This complex, 'AKAP79-D/D', was mixed with purified CaM in an equimolar ratio and incubated with the homobifunctional amine-reactive cross-linker disuccinimidyl suberate (DSS) in the presence of 100 μM Ca 2+ . Coomassie staining ( Fig. 1b ) and immunoblotting against AKAP79 ( Fig. 1c) or CaM ( Fig. 1d ) after electrophoresis on denaturing gels confirmed that cross-linking covalently coupled CaM and AKAP79. The most prominent band at 80 kD corresponds to cross-linked AKAP79-CaM heterodimers, whereas the band at 160 kD represents stabilization of 2AKAP79-2CaM tetramers, which is consistent with native MS and gel filtration studies, indicating that AKAP79 dimerizes 25, 27 . To determine which lysines had cross-linked within the complex, the sample was digested with trypsin, and cross-linked peptides were identified using liquid chromatography (LC)-MS/MS. A total of 213 peptides were identified from three biological replicates, each shot in technical duplicates. These consist of 47 interlinks between CaM and AKAP79, 148 links between AKAP79 peptides (intralinks or links between homodimeric AKAP proteins), 13 CaM-CaM intralinks, and 5 links between symmetrical peptides, indicating interlinks between AKAP79 homodimers (Supplementary Table 1 ). Such symmetrical dimeric interlinks were detected at three positions in AKAP79 (83-83, 50-50, 48-48), which is consistent with previous reports that AKAP79 dimerizes in a parallel conformation involving N-terminal contacts 25 . An exemplar MS/MS sequencing spectrum is shown for a peptide linked between K94 CaM and K99 AKAP79 (Fig. 1e ). The overall pattern of intralinks (grey) and interlinks (black) within and between AKAP79 and CaM is illustrated in Fig. 1f .
Interlinks between AKAP79 and CaM were restricted to lysines between residues 41 and 177 in the N-terminus of AKAP79 ( Fig. 1g) 25 . To narrow down the location of the CaM-binding site on AKAP79, we considered the frequency with which particular lysine pairs were observed in cross-linked peptides. Multiple detections of a particular link may arise as enzymatic digestion may lead to peptides of varying lengths containing the same cross-linking sites. In addition, the data set contains the data pooled from biological replicates (potential additional multiple identifications of cross-linked peptides originating from different charge states or technical duplicates were counted as the same unique cross-linked peptide). A high frequency of a particular lysine pairing therefore strongly indicates that the two amino acids are likely to be optimally positioned for cross-linking under native conditions. In this case, 66% of all interlinks were mediated between K94 in CaM (K94 CaM ) and either K90 AKAP79 (4 detections, Fig. 1g ), K96 AKAP79 (7 detections, Fig. 1g ) or K99 AKAP79 (16 detections, Fig. 1g ). The identification of this cross-linking hot-spot provided us with a reference point to triangulate the position of the CaM-binding site in AKAP79.
Location of the CaM-binding site in AKAP79. The cross-linking data suggested that CaM binds in the vicinity of AKAP79 lysines 90, 96, and 99. AKAP79 contains a predicted helical region between amino acids 79-86 in the vicinity of this cross-linking hot spot. To examine whether this could correspond to the CaMbinding site in AKAP79, we used a complementary method -the amplified luminescent proximity homogenous assay (alpha)screen technique-to scan the N-terminus of AKAP79 for sequences that could mediate interactions with CaM. Incubation of GST-AKAP79 (1-153), but not control GST, with biotinylated CaM brings streptavidin donor and anti-GST acceptor beads within 200 Å, which can be detected by measuring emission between 520 and 620 nm following illumination at 680 nm ( Fig. 2a, b ). Ca 2+ triggered CaM association with GST-AKAP79 (1-153) but not with GST alone (lanes 2 and 4, Fig. 2b , p = 2.2 × 10 −8 ). We screened peptides derived from the N-terminus of AKAP79 for their ability to reduce alphascreen emission. Twenty 20-mer peptides were synthesized corresponding to a walk in increments of 5 amino acids along the N-terminus of AKAP79 beginning at 21-40 (peptide 'A', Fig. 2c ) and ending at 116-135 (peptide 'T', Fig. 2c ). The effect of each peptide at 100 nM concentration on CaM-AKAP79 (1-153) interaction is shown in Fig. 2d as log2 emission ratios (with/without peptide). Consistent with the cross-linking data, the only two peptides encompassing residues 79 and 86 most effectively inhibited the interaction. Peptide M (positions 71-90) reduced the signal to 0.13 ± 0.02 compared to untreated samples; and peptide N (76-95) reduced the signal to 0.21 ± 0.03 of the untreated emission. No other peptides reduced emission below 0.60 relative to untreated samples. There is one other predicted helical sequence in the AKAP79 N-terminus, which falls between residues 33 and 48, but no peptides spanning this region produced a marked reduction in alphascreen signal (peptides C-F, Fig. 2d ).
To verify that CaM binds to the helix spanning residues 79-86, we first performed pull-down experiments using lysates from human embryonic kidney 293T (HEK293T) cells expressing fulllength FLAG-tagged AKAP79 variants ( Fig. 3a ). Wild-type AKAP79 associates with both CaM sepharose, and cAMP agarose NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01715-w ARTICLE by virtue of its ability to interact with type II regulatory (RII) subunits of PKA (lane 1, Fig. 3a ). Control experiments confirmed that CaM sepharose pull-down of WT AKAP79 was Ca 2+ -dependent ( Supplementary Fig. 2b ). Deletion of the AKAP79 anchoring helix (Δ391-400) prevents its association with cAMP agarose but does not affect binding to CaM sepharose (lane 4, Fig. 3a) , as expected. We tested two novel deletion mutants of AKAP79 lacking one or other of the two predicted helical sequences. Removal of residues 33-48 did not affect either CaM sepharose or cAMP agarose binding (lane 2, Fig. 3a ). However, deletion of residues 79-86 abolished binding to CaM sepharose but not cAMP agarose binding (lane 3, Fig. 3a ), which is consistent with the results of cross-linking ( Fig. 1g ) and peptide scanning ( Fig. 2d ). Removal of residues 79-86 also abolished interaction between GST-AKAP79 (1-153) and biotinylated CaM, according to the alphascreen assay ( Supplementary Fig. 2c ).
The predicted helical sequence spanning AKAP79 residues 79-86 is shown in Fig. 3b . The helix contains hydrophobic amino acids in a 1-4-7-8 pattern (yellow, Fig. 3b ) that does not conform to conventional 1-5-10 and 1-8-14 interaction motifs. Several basic amino acids lie at the immediate C-terminus of this hydrophobic cluster, and these are also highly conserved across the AKAP5 gene family (sequence LOGO, Fig. 3b ). To determine whether these basic amino acids contribute to the interaction, we compared how effectively peptides of different lengths could disrupt CaM-AKAP79 interaction. We calculated inhibition constants (K i -the concentration for half-maximal inhibition) for each peptide after incubating at different concentrations with GST-AKAP79 (1-153)/biotin-CaM and measuring alphascreen emission. The peptides analyzed are shown at the bottom of Fig. 3b . Whereas a 9-mer peptide spanning positions 1-9 exhibited low efficacy with a K i = 5.1 ± 1.2 μM (black line, Fig. 3c ), addition of the conserved amino acids G77 and A78 at the Nterminus brought the peptide efficacy into the nanomolar range (K i = 170 ± 40 nM, red line, Fig. 3c ). Extension to a 16-mer by inclusion of the polybasic sequence 'RRKRS' increased potency further with K i = 75 ± 8 nM (black line, Fig. 3d ), suggesting that these basic amino acids are involved in the interaction. Extension to 20-mer (red line, Fig. 3d , K i = 32 ± 2 nM) led to a similar fold increase in potency, but additional extension to the 26-mer produced little further improvement (black line, Fig. 3e , K i = 22 ± 1).
Some CaM targets, such as Munc13, present a major helical hydrophobic sequence with a shorter hydrophobic motif some distance downstream-at position 26 relative to the first anchor position 10 in the case of Munc13. The primary sequence of AKAP79 does not reveal any strong candidates for a second hydrophobic motif but we nevertheless tested whether mutating the best candidate, L101, affects the potency of the 26-mer peptide. L101A substitution led to no significant reduction in potency (K i = 24 ± 2, red line, Fig. 3e ). Overall the cross-linking, pull-down and alphascreen experiments show that AKAP79 contains an unconventional 1-4-7-8 motif beginning at W79 that is principally responsible for Ca 2+ -dependent CaM binding, supported by a stretch of~10 basic-rich amino acids following the motif.
CaM-dependence of interaction between calcineurin and AKAP79. Having established the location of the CaM-binding site in AKAP79, we next explored how the CaM-binding sites in AKAP79 and calcineurin contribute to Ca 2+ /CaM-dependent interaction between the N-terminus of AKAP79 and calcineurin. CaM could conceivably drive these interactions by binding either or both of its interaction sites in calcineurin and AKAP79. We first engineered two point mutations into calcineurin (I396A/ I400A) that CaM-calcineurin peptide crystal structures 28 indicate would render the phosphatase deficient in binding CaM (Fig. 4a ). Assays of phosphatase activity against a phosphorylated peptide confirmed that the I396A/I400A calcineurin variant is activated with a half-maximal CaM concentration (K CaM ) >20-fold higher (k = 670 ± 60 nM, red in Fig. 4b ) than the WT phosphatase (K CaM = 30 ± 12 nM, black in Fig. 4b ). Further details of curve fitting to determine these values are provided in Supplementary  fig. 3 . Next, we performed calcineurin pull-downs using GSTfusions to the N-terminus (1-153) of AKAP79 ( Fig. 4c ) in the presence of Ca 2+ and 100 nM CaM. Removing the 1-4-7-8 motif in AKAP79 (Δ79-86) led to marked reductions in pull down of Fig. 4c , n = 3, p = 0.0097). Conversely, phosphatase pull-down using GST-WT AKAP79 (1-153) was hardly altered when WT calcineurin was substituted with the I396A/ I400A variant (lanes 2 & 5, Fig. 4c ). These experiments suggest that the CaM-binding site in AKAP79 is required for driving the Ca 2+ -dependent calcineurin-AKAP79 interface, whereas calcineurin activation is not required. It is important to note that these experiments do not rule out the possibility that CaM binding to the phosphatase is required since this occurs at markedly lower concentrations than are required to activate the phosphatase 29 .
We also examined the effect of removing the 1-4-7-8 motif in live HEK293T cells using A-Kinase Activity Reporter 4 (AKAR4) 30 .
The FRET efficiency of AKAR4 increases upon phosphorylation of a central phosphorylation site such that the emission ratio at 535/485 nm presents a real-time readout of phosphorylation at a PKA site ( Fig. 4d ). We found that the baseline FRET ratio was increased by 8.1 ± 1.4 %-indicative of higher resting PKA phosphorylation-when the cells were co-transfected with Δ79-86 AKAP79 rather than WT AKAP79 ( Fig. 4e , n = 12, p = 8 × 10 −5 ). In sum, the experiments outlined in Fig. 4 show that removing the CaM-binding site in AKAP79 has consequences for PKA phosphorylation of cellular substrates.
Structure of CaM bound to its AKAP79 recognition site. To understand how the atypical '1-4-7-8' motif in AKAP79 is able to bind CaM, we attempted to co-crystallize CaM with peptides spanning the motif. Co-crystallization was achieved with a peptide corresponding to AKAP79 amino acids 77-92. X-ray diffraction images were collected to a resolution of 1.7 Å enabling determination of the crystal structure by molecular replacement using the C-lobe of CaM in complex with MARCKS peptide 11 . The structure was autobuilt using Buccaneer 31 , and refined in Coot 32 and PHENIX 33 . The assymetric unit contains two copies of CaM-AKAP79 peptide complex ( Supplementary Fig. 4a ). For each copy, AKAP79 amino acids 78-88 are visible in the electron density ( Supplementary Fig. 4b ). The two copies of the complex are similar with overall root mean standard deviation (rmsd) for Cα atoms = 0.834 Å. They show closer similarity between their Although only the C-lobes coordinate Ca 2+ , remarkably both CaM lobes engage the AKAP79 peptide (orange, Fig. 5b ). All four hydrophobic side-chains of the AKAP79 1-4-7-8 motif are accommodated within a hydrophobic pocket formed by the coming together of both CaM lobes ( Fig. 5b ). Trp79 in AKAP79 (W79 AKAP79 ) is deeply buried in a cleft within the CaM C-lobe, which is the canonical binding position for the first hydrophobic anchor amino acid. To determine the relative importance of different amino acids within the 1-4-7-8 motif for CaM association, we compared the ability of mutant peptides derived from AKAP79 77-96 to disrupt interactions between biotin-CaM and GST-AKAP79 (1-153). Whereas wild-type peptide reduced emission to 0.03 ± 0.01 relative to untreated samples, substitution of Trp79 with alanine greatly reduced the potency of the peptide (p = 0.0013) with a small reduction in emission to 0.78 ± 0.06 relative to the untreated condition (Fig. 5c ). The substitution V86A slightly reduced potency (0.17 ± 0.04 remaining emission, p = 0.019, compared to the WT peptide), while the helixdestabilizing mutation L82P also markedly reduced the potency of the peptide (0.61 ± 0.08 relative emission, p = 0.0034, Fig. 5c ). Alanine substitutions at positions '4' (L82) and '7' (L85) had no significant effect on potency, indicating that they are less essential for the interaction (lanes 3 and 4, Fig. 5c ). We also translated these findings into the context of full-length AKAP79 on the basis that studies with peptides might not capture the full complexity of the interaction. CaM sepharose pull-down experiments with purified full-length AKAP79-RIIα D/D complexes support a key role for W79 AKAP79 in mediating association with CaM. Whereas wild-type AKAP79 efficiently bound to CaM sepharose ( Fig. 5d ), both the deletion of positions 79-86, or substitution of tryptophan 79 for alanine, abolished binding (Fig. 5d ).
The binding mode is unusual following anchoring of Trp79 AKAP79 within the CaM C-lobe. Strikingly, the AKAP79 polypeptide twists away from CaM after position 86 (orange, Fig. 5b ), whereas most CaM-interacting proteins present single straight α-helices for interaction. CaM adopts a highly compact conformation to accommodate AKAP79. We searched for structural homologs of full-length CaM taken from the complex using the DALI server and returned no structural matches spanning both lobes with rmsd < 3 Å (Supplementary Table 2 ). This analysis confirms that, in this crystal structure, CaM adopts a conformation that has not been observed before.
The binding helix contains 3 10 helical character. The Ramachandran plot for amino acids in AKAP79 shows that six amino acids in the structure exhibit the geometry of right-handed helices (positions 80-85, Fig. 5e ). Whereas positions 80-83 exhibit αhelical backbone geometry (diamonds, Fig. 5e ), positions 84 and 85 possess more positive ψ angles that are characteristic of 3 10 helices (black triangles, Fig. 5e ). Analysis of the hydrogenbonding pattern within AKAP79 confirms that the AKAP79 helix NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01715-w ARTICLE exhibits 3 10 helicity at its C-terminus. The L85 AKAP79 backbone amino group H-bonds with the carbonyl group of L82 AKAP79 , and the equivalent atom in V86 AKAP79 also H-bonds with the carbonyl group of the amino acid three residues upstream ( Fig. 5f , striped lines). The characteristic triangular 3 10 helical conformation between amino acids 83 and 86 is most clearly visible when looking down the barrel of the AKAP79 helix (Fig. 5g ). The backbone groups of pairs 79-83 and 80-84 engage in α-helical Hbonds ( Fig. 5f, dotted lines) . This overall helical geometry enables AKAP79 to present an amphipathic helix, in which all four hydrophobic positions, including W79 AKAP79 and V86 AKAP79 (Fig. 5f ) are projected from the same side of the helix. This is the first example of a CaM-binding helix containing 3 10 helical character.
Analysis of Ca 2+ -dependence of the CaM-AKAP79 interaction.
Although there is no close structural homolog of the conformation of full-length CaM observed in complex with AKAP79, both the N-and C-lobes separately resemble conformations observed in other crystal structures of the Ca 2+ sensor (Supplementary Table 2 ). The C-lobe in particular has more than 20 structural homologs within an rmsd of 1 Å, including the Clobe of CaM in complex with the 1-8-14 motif of calcineurin 28 (rmsd 0.5 Å, Cα positions 80-147). However, in cases where the C-lobe adopts a similar conformation, the N-lobe is always markedly different with both EF hands coordinating Ca 2+ . in van der Waals contacts with this binding pocket. W79 AKAP79 is sandwiched between M124 CaM and M144 CaM ; L82 AKAP79 packs against F92 CaM ; L85 AKAP79 engages the side-chains of both F12 CaM and L39 CaM ; and V86 AKAP79 contacts both M145 CaM and I85 CaM (Fig. 6b ). The side-chains of A78 AKAP79 and T87 AKAP79 also contact hydrophobic patches on the surface of the C-lobe ( Fig. 6b ), whereas the side-chains of S81 AKAP79 and T87 AKAP79 form direct H-bonds with this same lobe (dotted lines, Fig. 6b ). The isolated N-lobe possesses fewer close structural homologs. The highest scoring match is to the N-lobe of CaM in complex with an IQ motif from myosin VI (rmsd 1 Å, Supplementary  Table 2 )-the class of motif that CaM binds in the Ca 2+ -free state 34 . All of the CaM N-lobe structural homologs retrieved by DALI, including structures of apo CaM 35 , are closed and Ca 2+ -free (Supplementary Table 2 ). Although CaM also employs a closed N-lobe to engage myosin VI, the relative orientations of the N-and C-lobes are markedly different in this complex (black, Fig. 6c ) compared to with AKAP79 (blue, Fig. 6c ). For example, E7 CaM , Q8 CaM and E11 CaM , which engage in H-bonds with AKAP79, are not involved in the interaction with myosin VI and instead face into solution in the CaM-myosin complex. Closer inspection of the CaM-AKAP79 peptide complex reveals that Nlobe H-bonds, involving residues including E7 CaM , Q8 CaM and E11 CaM , enable CaM to accommodate the atypical AKAP79 helix (Fig. 6d) . Notably, the side-chain of E11 CaM H-bonds to the backbone carbonyl of S81 AKAP79 , thus satisfying an H-bond lost in the transition from α to 3 10 helix (marked by an asterisk in Fig. 5f) . Similarly, the side-chain of Q8 CaM fulfills a helix-capping function in H-bonding to the backbone carbonyl of L85 AKAP79 (Fig. 6d ). In addition to this network of H-bonds, N-lobe residues L39 CaM and F12 CaM form a hydrophobic pocket that enables van der Waals interactions with the side-chain of L85 AKAP79 ( Supplementary Fig. 4c ).
The crystal structure suggests that Ca 2+ binding to the CaM Nlobe is not required for binding AKAP79. To test this, we compared the ability of CaM mutants unable to bind Ca 2+ in either the N-lobe (CaM12) or C-lobe (CaM34) to inhibit interaction between biotin-CaM and GST-AKAP79 (1-153). CaM12 inhibited the interaction with a similar K i (91 ± 6 nM, red line, Fig. 6e ) to wild-type CaM (108 ± 8 nM, black line), consistent with the notion that Ca 2+ binding to the CaM N-lobe is not required for interaction with AKAP79. CaM34 (K i = 930 ± 130 nM, blue line, Fig. 6e ) was a significantly less potent inhibitor of the interaction, which supports the idea that generation of the open conformation of the C-lobe by Ca 2+ binding enables interaction with AKAP79. Although Ca 2+ binding to the CaM Nlobe is apparently not required for association with AKAP79, we found that CaM still associates with AKAP79 at relatively low Ca 2+ concentrations: alphascreen measurements show that the half-maximal concentrations of free Ca 2+ [Ca 50 ] for CaM binding to AKAP79 and calcineurin are similar (Fig. 6f ). Biotin-CaM bound to GST-calcineurin with Ca 50 = 0.41 ± 0.01 μM (green, Fig. 6f ), whereas the concentration was slightly increased to 0.64 ± 0.01 μM when the same experiment was performed with GST-AKAP79 (1-153) (orange, Fig. 6f ). Ca 2+ binding to CaM was highly cooperative in both cases (calcineurin, n = 3.2 ± 0.2; AKAP79, n = 4.4 ± 0.3). The small difference in Ca 2+ sensitivity suggests that at certain intermediate cellular Ca 2+ concentrations, calcineurin may be active while in complex with AKAP79, while the CaM-binding site in the anchoring protein remains unoccupied. Overall, the structural and alphascreen data show despite an unusual binding mode, Ca 2+ sensitivity of the interaction with AKAP79 is similar to interactions with canonical CaM target sequences.
CaM adopts a highly compact conformation to bind AKAP79. There are striking differences between the binding mode of CaM with AKAP79 in comparison to that observed in complexes containing class 1-5-10 and class 1-8-14 sequences. In complex with AKAP79, CaM adopts a highly compact conformation (Fig. 7a ) exposing only 8700 Å 3 surface area. This reflects the unusually short spacing 9 of 11.9 Å between Cα atoms of the terminal hydrophobic anchor positions W79 AKAP79 and V86 AKAP79 . In comparison, CaM presents 9300 Å 3 total surface area when binding to the 1-5-10 motif of CaMKII (Fig. 7b, 14 .4 Å between anchor positions), and 9900 Å 3 when binding the 1-8-14 motif of calcineurin (Fig. 7c, 19 .5 Å between anchor positions). Another marked difference between AKAP79 and 1-5-10/1-8-14 motifs is the path of the recognition motif through CaM. The binding sequence in AKAP79 does not form a single straight helix, but twists out from CaM after L85 AKAP79 with dihedral angles characteristic of a β-sheet for positions equivalent to '9' and '10'. Concomitantly, CaM buries only 740 Å 3 in the interaction with AKAP79 ( Fig. 7a ). When the three binding modes are viewed from the same angle looking down on the amphiphilic side of the binding helix, only the class 1-5-10 and 1-8-14 motifs pass underneath the CaM linker (grey, Fig. 7a-c) . As a result, the interfaces with CaMKII (1400 Å 3 , Fig. 7b ) and calcineurin (1200 Å 3 , Fig. 7c ) are much larger.
Discussion
This investigation has generated multiple findings concerning the structure and function of AKAP79 regulation by CaM, and the results have wider implications for regulation by CaM. The CaM site in AKAP79 had eluded discovery for 20 years following the 
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1400 of 9300 Å 3 CaM buried Mapping the site has enabled us to perform the first experiments using CaMbinding-deficient variants of AKAP79 to establish that Ca 2+ /CaM-dependent interactions between AKAP79 and calcineurin require the CaM-binding site in AKAP79. We also demonstrated that ablating the CaM-binding site in AKAP79 increases resting PKA phosphorylation in HEK293T cells. The binding mode observed between CaM and AKAP79 further expands the documented binding capabilities of CaM 9 . The CaM-AKAP79 crystal structure reveals three abilities of CaM: it can adopt an extremely compact conformation (8700 Å surface area, Fig. 7a ); associate with sequences containing 3 10 helical turns; and bind a target using both lobes where only the C-lobe is in the open Ca 2+ -activated conformation (Fig. 5a ). Overall, the study highlights the remarkable flexibility of CaM, and the utility of XL-MS for identifying protein-protein interaction sites. Binding of Ca 2+ /CaM to AKAP79 can have two effects: it can trigger an additional interface with calcineurin (Fig. 4c) , and it has previously been shown to reduce binding of the anchoring protein to vesicles containing acidic phospholipids 19 . The second polybasic sequence in AKAP79 (region 'B' between positions 75-108) is particularly important for PIP 2 binding 19 . Six basic amino acids fall within or at the immediate C-terminus of the 1-4-7-8 motif (lysines 83 and 90; arginines 84, 88, 89 and 91) within region B. It appears likely that CaM occludes these six basic amino acids upon binding, thereby releasing the anchoring protein from acidic phospholipid headgroups. The Ca 2+ /CaMdependent calcineurin interaction site also falls within the Nterminus of AKAP79. In this study, experiments with the reporter AKAR4 indicate that removing the 1-4-7-8 motif within AKAP79 elevates resting PKA phosphorylation in HEK293T cells (Fig. 4e ). However, much remains to be understood concerning the purpose of the Ca 2+ /CaM-sensitive AKAP79-calcineurin interface. Comparison of knockin mice containing targeted ablations of the constitutive PKA and calcineurin anchoring sites in AKAP150 has proved to be highly valuable for disentangling the roles of these sites in insulin signaling and long-term depression 12, 14 . A similar approach incorporating mice containing knockin variants of AKAP150 lacking the 1-4-7-8 motif may now be applied now the site is mapped.
We were curious to investigate whether the binding motif in AKAP79 is a one-off, or if it might represent the first example of a hitherto unappreciated class of CaM interaction motif (Fig. 7d ). On the basis of the AKAP79-CaM crystal structure, we developed a position-specific scoring matrix to search the human proteome for potential 1-4-7-8 motifs with Scansite 3. The best 100 matching sequences are listed in Supplementary Table 3 . The list is likely to contain many false positives but contains several sites that warrant further investigation. The list includes five potential 1-4-7-8 motifs in other AKAPs: three similar sequences within Gravin, one in BIG1, and one in BIG2. A previous study identified a~200 amino acid region of Gravin that can bind CaM without precisely defining the binding sites 36 : all three potential 1-4-7-8 motifs (with initial tryptophan anchors at positions 610, 759, and 804) fall within this region. The search also retrieved a potential 1-4-7-8 motif present in seven of the ten voltagedependent Ca 2+ channel pore-forming α subunits (Ca V 1 and Ca v 2-type subunits, Supplementary Table 3 ). The sequence falls within a long helix in a short intracellular loop between transmembrane helices S4 and S5 in domain II 37 that moves upon voltage-dependent activation 38 . Conceivably access to this site could be altered upon voltage-dependent activation of the channels, providing a mechanism for coupling Ca 2+ and depolarization to channel regulation. Additional putative 1-4-7-8 sites of note include one potential site close to the membrane-tethered Cterminus of BCL-2, a key anti-apoptotic protein 39 . It will be exciting to see which of this long list of putative sites prove to be high affinity CaM-binding sites with physiological significance.
Methods
Protein expression and purification. All protein purification steps were performed at 4°C. To express AKAP79 in bacteria in a non-aggregated form, we cloned the D/D domain (residues 1-45) of human PKA RIIα into pGEX6P1 for expression as a PreScission-cleavable fusion at the N-terminus of GST, and included a second cistron containing N-terminally 6xHis-tagged AKAP79. Primer sequences are listed in Supplementary table 4 . Co-expression of AKAP79-D/D was induced in BL21 (DE3) E. coli (Novagen) at OD 600 = 0.5 with 0.4 mM IPTG, and the cells were harvested after 3 h at 37°C. The cell pellet was resuspended in lysis buffer (30 mM Tris-HCl pH 8, 300 mM NaCl, 10 mM imidazole, 1 mM benzamidine, one EDTA-free protease inhibitor tablet/100 mL (Roche), 0.1 mg mL −1 lysozyme), sonicated briefly, and clarified by centrifugation at 40,000 × g for 30 min. The supernatant was collected and incubated with Ni-NTA agarose (Qiagen) for 2 h prior to elution in 30 mM Tris-HCl pH 7.5, 300 mM NaCl, 300 mM imidazole, 1 mM benzamidine. The eluted protein was buffer exchanged into glutathione sepharose binding buffer (25 mM Tris pH 7.4, 500 mM NaCl, 2 mM DTT, 1 mM EDTA, 1 mM Benzamidine) using a Sephadex G-25 column, before 3 h incubation with glutathione sepharose 4B (GE Life Sciences). AKAP79-D/D was eluted by overnight incubation with PreScission protease (GE Life Sciences). In the final purification step, AKAP79-D/D complex eluted between 0.4 and 0.5 column volumes from a Superdex-200 gel filtration column in 20 mM Hepes pH 7.5 and 200 mM NaCl ( Supplementary Fig. 1b ). AKAP79-Δ79-86 and W79A variants, in complex with the RIIα D/D domain, were expressed and purified in the same way. Gel filtration elution profiles confirm that deletion of amino acids 79-86 does not affect the peak elution volume of AKAP79-RIIα D/D upon gel filtration ( Supplementary Fig. 1b ). GST fusion proteins ( Supplementary Fig. 1d , e, f), and calcineurin (WT and I396A/I400A; Supplementary Fig. 1h , i) were purified, using affinity to glutathione sepharose and size exclusion chromatography (SEC) 25 , after expression in BL21 (DE3) E. coli.
For crystallography, human CaM was cloned into pET28-a for expression of untagged protein in E. coli BL21 (DE3) cells. CaM was expressed by overnight incubation at 37°C in 3 L auto-inducing media 40 , yielding a cell pellet of~30 g. The pellet was resuspended in 150 mL lysis buffer (25 mM Tris pH 7.4, 500 mM NaCl, 1 mM EDTA, 2 mM DTT, 1 mM Benzamidine, 0.1 mg/mL −1 lysozyme), and sonicated briefly prior to high-speed centrifugation (20,000 × g, 30 min). The clarified lysate was supplemented up to 5 mM CaCl 2 , before incubation with phenyl sepharose (GE Life Sciences) for 3 h. After washing (50 mM Tris pH 7.4, 1 mM CaCl 2 , 500 mM NaCl), CaM was eluted in 10 mL EDTA buffer (50 mM Tris pH 7.4, 1 mM EDTA). The eluate was diluted in buffer containing 20 mM Tris pH 8.5, 2 mM DTT, 1 mM EDTA to a final NaCl concentration of~20 mM, enabling binding to a 1 mL Resource Q column (GE Life Sciences). CaM was eluted from the Resource Q column with a salt/pH gradient by varying the proportions of a mixture of buffers A (20 mM Tris pH 8.5, 20 mM NaCl, 1 mM benzamidine, 2 mM DTT, 1 mM EDTA) and B (20 mM Tris pH 7.2, 1 M NaCl, 1 mM benzamidine, 2 mM DTT, 1 mM EDTA). Finally, CaM was dialysed into water and lyophilized using a vacuum concentrator. This protocol yields~1.5 mg purified CaM per L culture ( Supplementary Fig. 1c ). Vectors for expressing CaM12 (D20A/D56A) and CaM34 (D93A/D129A) variants were generated using site-directed mutagenesis of pET28-a-CaM, and these variants were expressed in the same way and purified using phenyl sepharose and gel filtration. For XL-MS experiments, CaM was expressed with a PreScission-cleavable GST tag, and purified by affinity to glutathione sepharose, PreScission cleavage and SEC 25 . Coomassie stained SDS-PAGE gels show the purity of biotinylated CaM, CaM, CaM12, and CaM34 ( Supplementary Fig. 1g, j) .
Cross-linking coupled to mass spectrometry. AKAP79-D/D and CaM were mixed at a 1:1 molar ratio to a final concentration of 1 mg/mL in 100 μL buffer containing 20 mM Hepes pH 7.5, 200 mM NaCl and 100 μM CaCl 2 . Cross-linking was inititated by adding 2 μL H12/D12 DSS (Creative Molecules) from a 25 mM stock prepared in DMSO. After 30 min incubation at 30°C in a thermomixer set to 300 rpm, reactions were terminated by addition of 5 μL from a 1 M stock of ammonium bicarbonate. Each 100 μg cross-linked sample was enzymatically digested with trypsin and subsequently enriched by SEC for cross-linked peptides. LC-MS/MS analysis was carried out on an Orbitrap Elite mass spectrometer (Thermo Scientific). The data were searched using xQuest 41 in ion-tag mode with a precursor mass tolerance of 10 p.p.m. For matching of fragment ions, tolerances of 0.2 Da for common-ions and 0.3 Da for cross-link ions were applied. Fragment ions were analyzed in an ion trap, trading lower mass accuracy for increased sensitivity and measuring speed. Potential cross-links were statistically validated from fragment ion spectra and false discovery rates (FDR) were assigned using xProphet 42 . Cross-linked AKAP79-D/D-CaM samples were prepared in biological triplicate, and each of these was measured as technical duplicates. For each experiment, the final data set was restricted to high-confidence unique cross-links with both ID scores >20 and FDRs <0.05. Spectra of potential crosslinks were also visually inspected to ensure good matches of ion series on both cross-linked peptide chains for the most abundant peaks.
Pull-down assays. For pull-down assays involving N-terminally FLAG-tagged AKAP79 variants, HEK293T cells (American Type Culture Collection) were initially cultured in DMEM supplemented with GlutaMAX, Penicillin/Streptomycin, and 10% (v/v) fetal bovine serum (all supplied by Gibco). 10 cm diameter plates were transfected at 60 % confluence using 4 μg pcDNA3.1-FLAG-AKAP79 and 16 μL Fugene 6 (Promega). Cells were transfected with WT, Δ33-48, Δ79-86, or Δ391-400 ('ΔPKA') AKAP79. 3 days after transfection, cells were collected and lysed in 1 mL HEK293T buffer (30 mM Tris pH 7.4, 150 mM NaCl, 1% Igepal CA-630, 1 mM EDTA, 1 mM benzamidine, 2 mM DTT). Following sonication, lysates were clarified by centrifugation, then split equally for incubation with either 20 μL CaM sepharose 4B (GE Healthcare) or 20 μL 8-AEA-cAMP-agarose (Biolog) beads. After overnight incubation, beads were washed with 6 × 1 mL HEK293T buffer, and finally protein was eluted with 40 μL 1 × LDS sample buffer (ThermoFisher). For CaM sepharose pull-downs, the clarified lysate and wash buffer were supplemented with 3 mM CaCl 2 . FLAG-AKAP79 variants were detected using rabbit anti-FLAG primary antibody (Sigma), and goat anti-rabbit-HRP-conjugate secondary antibody (Bio-Rad). An additional experiment was performed to confirm that binding of WT AKAP79 to CaM-sepharose is Ca 2+ -dependent. In this case, HEK293T cells were transfected with pcDNA3.1-AKAP79-V5 (WT or Δ79-86). The lysate from each plate was clarified by centrifugation, divided into two, and one half of the material was supplemented with 3 mM CaCl 2 . Each half was incubated with 20 μL CaM sepharose 4B overnight, then washed with 6 × 1 mL HEK293T buffer (supplemented with 3 mM CaCl 2 , where appropriate) the following morning, and eluted in 1 × LDS sample buffer. AKAP79-V5 was detected using anti-V5-HRP-conjugate antibody (ThermoFisher). For pull-down experiments using AKAP79-D/D complexes purified from bacteria, pull-down was performed using a similar procedure. In this case, 0.5 μg purified protein was added in each pull-down. Bound protein was detecting by first eluting with Ca 2+ -free HEK293T buffer containing 1 mM EDTA, and then immunoblotting with anti-AKAP79 (Millipore) antibody.
To determine which CaM-binding site enables Ca 2+ -dependent interaction between the N-terminus of AKAP79 and calcineurin, 1 μg GST-AKAP79 1-153 (WT or Δ79-86) was incubated with 2 μg calcineurin (WT or I396A/I400A) in pull-down buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% Igepal CA-630, 0.25% sodium deoxycholate, 1 mM EDTA, 1 mM benzamidine) containing 100 nM CaM. The samples were supplemented with 3 mM CaCl 2 where appropriate. The samples were incubated with 2 μL magnetic glutathione bead slurry (Pierce) for 4 h, washed 4 times in pull-down buffer supplemented with 50 nM CaM, and 3 mM CaCl 2 where appropriate. Finally, proteins were eluted from the magnetic beads in 50 μL 1 × LDS sample buffer. Calcineurin pull-down was detected using mouse anticalcineurin antibody (Catalog number 610259, BD Biosciences, 1:500 dilution).
Amplified luminescent proximity homogeneous assay screens. To prepare biotin-labeled CaM for use in alphascreen assays, 1 mg purified CaM was incubated with a two-fold molar excess of EZ link NHS Biotin (Pierce) in 20 mM Na Hepes pH 7.5, 200 mM NaCl. Labeling was terminated after 30 min at 22°C by supplementing with Tris-HCl pH 7.4 to a final concentration of 50 mM. Biotininylated CaM was separated from free biotin by SEC yielding >200 μL biotininylated CaM at 80 μM. In general, assays were performed in 50 μL buffer consisting of 20 mM HEPES pH 7.2, 100 mM NaCl, 0.1% BSA, 1 mM EGTA, 5 mM MgCl 2 , 1 mM CaCl 2 . CaCl 2 was excluded where appropriate. A PEPscreen was ordered from Sigma containing the following peptides (~2 mg each): 20-mer peptides walking through the N-terminus of AKAP79 in 5-amino-acid increments, starting at 21-40 and ending at 116-135 for a total of 20 peptides; and 20-mer peptides corresponding to AKAP79 (77-96) containing either WT sequence or the substitutions W79A, L82A, L85A, V86A, L82P. The following high (>95%) purity peptides were ordered from Biomatik: '9-mer' (AKAP79 positions 79-87), '11-mer' (77-87), '16mer' (77-92), '20-mer' (77-96), and '26-mer' (77-102) both with and without the substitution L101A.
For all alphascreen experiments, GST-AKAP79 (1-153) and biotinylated CaM were first preincubated for 1 h at 22°C in the presence of the appropriate peptide of unbiotinylated CaM additives. Biotin-CaM was included at 10 nM in all mixtures, whereas GST-AKAP79 varied between experiments as follows: 3 nM (Fig. 2d, Fig. 3c-e, Supplementary Fig. 2c ), 6 nM (Fig. 5f ), and 8 nM (Fig. 2d ). To determine the K Ca for CaM binding to calcineurin and AKAP79, the CaCl 2 concentration was varied to produce different free Ca 2+ concentrations on the basis of calculations using maxchelator 43 . After initial incubations, anti-GST acceptor beads (PerkinElmer) were added at 10 ng/μL. After 30 min, streptavidin donor beads were also added at 10 ng/μL. After 1 h further incubation with vigorous shaking in a thermomixer (1200 r.p.m.), light emission at 568 nm was measured following excitation with a 680 nm laser using a Mithras LB 940 (Berthold Technologies).
Protein crystallization. Peptide corresponding to AKAP79 positions 77-92 (GAWASLKRLVTRRKRS) was synthesized at 96% purity (Biomatik). Lyophilized CaM was resuspended in 10 mM CaCl 2 at 7.5 mg/mL and mixed with a 3:1 molar excess of peptide. Crystals were grown at 22°C using hanging-drop vapor diffusion by mixing 1 μL of CaM solution with 1 μL mother liquor (2.4 M ammonium sulphate, 50 mM citrate pH 5.4, 0.3 M NDSB-195). After growth for one month, crystals were flash-frozen in liquid N 2 using mother liquor supplemented with 3.5 M ammonium sulphate.
X-ray diffraction data collection and processing. The diffraction data were collected at the Diamond Light Source (Harwell, UK) beamline I24. Diffraction images were processed using iMosflm 44 and merging/scaling of reflection intensities was performed by AIMLESS 45 . AIMLESS indicated an appropriate resolution limit of 1.7 Å (1.73-1.7 Å shell: I/σI = 3.1, CC 1/2 = 0.552). Initial phases were obtained by molecular replacement in PHASER 46 using the C-lobe of CaM (residues 85-148, PDB 1IWQ) as the search model. This confirmed that two copies of the CaM-AKAP79 peptide complex are present in the asymmetric unit. Automated model building was performed in Buccaneer 31 . The model was refined by rounds of manual model building in Coot 32 and automated refinement in PHENIX 33 . Refinement was performed using 20 translation/libration/screw groups defined automatically by PHENIX. The structure was validated with MolProbity 47 . The data collection and refinement statistics are shown in Table 1 . Stereo images of the 2F o −F c electron density map clipped to the AKAP79 peptide are shown in Supplementary Fig. 4b .
Structure and sequence analysis. Structural representations of the complex (chains B and D of the asymmetric unit unless otherwise stated) were rendered using Pymol (www.pymol.org). Secondary structure prediction was performed using Jpred3 48 . Alignments, and LOGO plots of AKAP5 sequences were retrieved from the ensembl database (www.ensembl.org). Distances were calculated using NCONT, and solvent accessibility was determined using AREAIMOL 49 . Automated H-bond identification was performed using UCSF Chimera 50 , 3D structural homologs were identified using the DALI server 51 , and pairwise structural alignments were performed using GESAMT 49 .
A-kinase activity reporter assays. Fluorescence-based recordings of PKA activity were performed in HEK293T cells attached to 96-well plates. HEK293T cells were cultured and transfected in the same way as for pull-down assays. In this case, cells were transfected at 60 % confluence in 6-well plates using 1 μg DNA/4 μL Fugene 6 per well. The DNA consisted of a mixture of 0.3 μg pcDNA3.1-FLAG-AKAP79 (WT or Δ79-86) and 0.7 μg AKAR4 DNA. 2 days after transfection, the cells were detached using trypsin and resuspended in 3 mL supplemented DMEM, then replated at 100 μL/well in 96-well black-walled plates (Molecular Probes) that had been coated overnight with poly-l-lysine (Sigma). The following morning, the media was exchanged for PBS (100 μL per well), and FRET ratios were immediately determined using a Mithras LB 940 plate-reader (Berthold Technologies) controlled by a computer running Mikrowin 2000 software. To enable recordings using AKAR4 30 , the plate reader was fitted with a 420 nm excitation filter (Berthold no. 39452), and emission filters at 485 nm (no. 40271) and 535 nm (no. 40273).
Protein phosphatase assays. Protein phosphatase activity was determined by measuring phosphate release from phosphorylated RII peptide 
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(DLDVPIPGRFDRRVpSVAAE) synthesized at >95% purity (Biomatik). Assays were performed with either WT or I396A/I400A calcineurin at 20 nM in 50 μL reactions containing different concentrations of CaM in phosphatase assay buffer (20 mM Na Hepes, 100 mM KCl, 0.1% BSA, 1 mM EGTA, 6 mM MgCl 2 , 1 mM CaCl 2 ). Each assay was initiated by adding pRII substrate (75 μM final concentration), and terminated after 1 h at 30°C by addition of 50 μL Biomol Green (Enzo Life Sciences). Phosphate release was determined by measuring absorbance at 630 nm using an ELx800 spectrophotometer (Biotek) after color had been allowed to develop for 30 min at 22°C.
Motif-based scanning for 1-4-7-8 CaM-binding sites. Scansite 3 was used to perform searches for putative 1-4-7-8 class CaM-binding motifs 52 . To identify potential 1-4-7-8 motifs, we assembled a position-specific scoring matrix file guided by contacts between AKAP79 and CaM in the crystal structure: the strongest weighting was assigned to the first anchor tryptophan, followed by hydrophobic amino acids at positions 4, 7, and 8. Conservative substitutions that could be accommodated according to the crystal structure were assigned intermediate weightings. The basic amino acids lysine and arginine were equally weighted at positions '5' and '6'. The full matrix is shown in supplementary Fig. 5 . The matrix was used to search Homo sapiens protein sequences within the SwissProt database (20252 total input proteins). 570 predicted sites were found, with a median score = 0.633, and median absolute deviation = 0.108. The top 100 highest scoring predicted sites are listed in supplementary Table 3 .
Statistical analysis. Densitometry was performed using ImageJ 53 . Two-tailed student's t tests were used to calculate p values for the differences between mean values (n ≥ 3 for all experiments). Densitometry was performed using ImageJ 53 . Curve fitting to determine K Ca and K i values was performed by fitting data to Hill functions by iterative least squares minimization using ORIGIN software (Origi-nLab). K CaM co-efficients for calcineurin activation were calculated by fitting to Michaelis-Menten functions containing a cooperativity variable ( Supplementary  Fig. 3 ).
Data availability. The coordinate and structure factor data of the CaM-AKAP79 (77-92) complex has been deposited in the Protein Data Bank (PDB) with the accession code 5NIN. Uncropped images of blots and gels are shown in Supplementary Fig. 6 . The other data are available from the corresponding author upon reasonable request.
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